Disease Stocks List

Disease Stocks Recent News

Date Stock Title
Nov 22 HUMA Humacyte to Present Efficacy and Safety Results from V007 Phase 3 AV Access Clinical Trial at the 51st Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITH)
Nov 22 PSTV Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
Nov 22 CYTK Cytokinetics price target raised to $103 from $99 at Mizuho
Nov 21 CYTK Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
Nov 21 GOSS All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy
Nov 21 HUMA Insider Buyers At Humacyte Likely Disappointed With 17% Slide
Nov 21 HUMA Humacyte Clinical Results Highlighting Benefit of the ATEV™ in the Repair of Civilian and Military Arterial Injuries Published in JAMA Surgery
Nov 21 PSTV Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases
Nov 20 CYTK Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Nov 19 CYTK Cytokinetics and Bayer partner to develop for aficamten in Japan
Nov 19 CYTK Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 CYTK Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
Nov 19 CYTK Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
Nov 19 CYTK Bayer acquires rights to Cytokinetics' heart drug in Japan
Nov 19 CYTK Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
Nov 18 CRDL Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Nov 18 HUMA Humacyte Presents Preclinical Results of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting at American Heart Association’s Scientific Sessions 2024
Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
Disease

A disease is a particular abnormal condition that negatively affects the structure or function of part or all of an organism, and that is not due to any external injury. Diseases are often construed as medical conditions that are associated with specific symptoms and signs. A disease may be caused by external factors such as pathogens or by internal dysfunctions. For example, internal dysfunctions of the immune system can produce a variety of different diseases, including various forms of immunodeficiency, hypersensitivity, allergies and autoimmune disorders.
In humans, disease is often used more broadly to refer to any condition that causes pain, dysfunction, distress, social problems, or death to the person afflicted, or similar problems for those in contact with the person. In this broader sense, it sometimes includes injuries, disabilities, disorders, syndromes, infections, isolated symptoms, deviant behaviors, and atypical variations of structure and function, while in other contexts and for other purposes these may be considered distinguishable categories. Diseases can affect people not only physically, but also mentally, as contracting and living with a disease can alter the affected person's perspective on life.
Death due to disease is called death by natural causes. There are four main types of disease: infectious diseases, deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases. Diseases can also be classified in other ways, such as communicable versus non-communicable diseases. The deadliest diseases in humans are coronary artery disease (blood flow obstruction), followed by cerebrovascular disease and lower respiratory infections.The study of disease is called pathology, which includes the study of etiology, or cause.

Browse All Tags